Immuron CEO, Steven Lydeamore, to host an investor webinar

Rhea-AI Summary

MELBOURNE, Australia, Aug. 29, 2022 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN) invites investors to a live webcast hosted by CEO Steven Lydeamore on September 7, 2022, at 9:00 AM AEST. The event aims to discuss the company's proprietary technology for gut-mediated disease treatment. Interested participants can register in advance for the webinar. This press release is authorized by the directors of Immuron Limited, which is focused on developing orally delivered polyclonal antibodies from bovine colostrum.

MELBOURNE, Australia, Aug. 29, 2022 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform for prevention and treatment of gut-mediated diseases; invites investors to join a live webcast hosted by Steven Lydeamore, CEO of Immuron Limited.

Wednesday, 7 September 2022 at 9.00am Australian Eastern Standard Time (AEST). Register in advance for this webinar: https://us02web.zoom.us/webinar/register/WN_sCS7O27uRxWQPC3Z6ILa8g After registering, you will receive a confirmation email containing information about joining the webinar.

This release has been authorised by the directors of Immuron Limited.

COMPANY CONTACT: Steven Lydeamore Chief Executive Officer Ph: +61 (0)3 9824 5254 info@immuron.com

About Immuron
Immuron Limited (ASX: IMC, NASDAQ: IMRN) is a commercial and clinical-stage Australian biopharmaceutical company with a proprietary technology platform focused on a novel class of orally delivered polyclonal antibodies produced from hyperimmune antibody-rich bovine colostrum, for prevention and treatment of gut-mediated diseases.

For more information visit: http://www.immuron.com

 

FAQ

What is the date and time of Immuron Limited's webcast?

The webcast will take place on September 7, 2022, at 9:00 AM AEST.

Who is hosting the Immuron Limited webcast?

The webcast is hosted by Steven Lydeamore, CEO of Immuron Limited.

How do I register for the Immuron Limited webcast?

You can register for the Immuron Limited webcast at this link: https://us02web.zoom.us/webinar/register/WN_sCS7O27uRxWQPC3Z6ILa8g.

What is the focus of Immuron Limited's proprietary technology?

Immuron Limited focuses on the prevention and treatment of gut-mediated diseases using orally delivered polyclonal antibodies from bovine colostrum.

What stock symbols are associated with Immuron Limited?

Immuron Limited is listed under ASX: IMC and NASDAQ: IMRN.